Market Reports Center

PHARMACEUTICALS


Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals. The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports listed under our Pharmaceuticals category

Total 20460 Reports Found - Showing Reports From 1 To 25

In this report, the global Resveratrol market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Resveratrol in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India G

View Details

In this report, the global Captopril API market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Captopril API in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia Indi

View Details

This report studies the Lenalidomide market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Lenalidomide market by product type and applications/end industries. The global Lenalidomide market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Th

View Details

Acute Asthma Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Acute Asthma Global Clinical Trials Review, H1, 2017" provides an overview of Acute Asthma clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Asthma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 &

View Details

Acute and Sub-Acute Bursitis Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Acute and Sub-Acute Bursitis Global Clinical Trials Review, H1, 2017" provides an overview of Acute and Sub-Acute Bursitis clinical trials scenario. This report provides top line data relating to the clinical trials on Acute and Sub-Acute Bursitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offe

View Details

Actinic (Solar) Keratosis Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Actinic (Solar) Keratosis Global Clinical Trials Review, H1, 2017" provides an overview of Actinic (Solar) Keratosis clinical trials scenario. This report provides top line data relating to the clinical trials on Actinic (Solar) Keratosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage

View Details

Acromegaly Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Acromegaly Global Clinical Trials Review, H1, 2017" provides an overview of Acromegaly clinical trials scenario. This report provides top line data relating to the clinical trials on Acromegaly. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), pha

View Details

Acquired (Autoimmune) Hemolytic Anemia Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Acquired (Autoimmune) Hemolytic Anemia Global Clinical Trials Review, H1, 2017" provides an overview of Acquired (Autoimmune) Hemolytic Anemia clinical trials scenario. This report provides top line data relating to the clinical trials on Acquired (Autoimmune) Hemolytic Anemia. Report includes an overview of trial numbers and their average enrollment in top countries con

View Details

Acne Vulgaris Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Acne Vulgaris Global Clinical Trials Review, H1, 2017" provides an overview of Acne Vulgaris clinical trials scenario. This report provides top line data relating to the clinical trials on Acne Vulgaris. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G

View Details

Acne And Related Disorders Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Acne And Related Disorders Global Clinical Trials Review, H1, 2017" provides an overview of Acne And Related Disorders clinical trials scenario. This report provides top line data relating to the clinical trials on Acne And Related Disorders. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers cover

View Details

Acidity Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Acidity Global Clinical Trials Review, H1, 2017" provides an overview of Acidity clinical trials scenario. This report provides top line data relating to the clinical trials on Acidity. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial st

View Details

Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2017" provides an overview of Acid Indigestion / Heartburn/ Pyrosis clinical trials scenario. This report provides top line data relating to the clinical trials on Acid Indigestion / Heartburn/ Pyrosis. Report includes an overview of trial numbers and their average enrollment in top countries conduct

View Details

Abscess Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Abscess Global Clinical Trials Review, H1, 2017" provides an overview of Abscess clinical trials scenario. This report provides top line data relating to the clinical trials on Abscess. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial st

View Details

Abortion Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Abortion Global Clinical Trials Review, H1, 2017" provides an overview of Abortion clinical trials scenario. This report provides top line data relating to the clinical trials on Abortion. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, tria

View Details

Abdominal Pain Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Abdominal Pain Global Clinical Trials Review, H1, 2017" provides an overview of Abdominal Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Abdominal Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, countr

View Details

Abdominal Obesity Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Abdominal Obesity Global Clinical Trials Review, H1, 2017" provides an overview of Abdominal Obesity clinical trials scenario. This report provides top line data relating to the clinical trials on Abdominal Obesity. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by re

View Details

Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2017" provides an overview of Abdominal Aortic Aneurysms clinical trials scenario. This report provides top line data relating to the clinical trials on Abdominal Aortic Aneurysms. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers cover

View Details

Abdominal Abscess Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Abdominal Abscess Global Clinical Trials Review, H1, 2017" provides an overview of Abdominal Abscess clinical trials scenario. This report provides top line data relating to the clinical trials on Abdominal Abscess. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by re

View Details

Pancreatic Cancer Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Pancreatic Cancer Global Clinical Trials Review, H1, 2017" provides an overview of Pancreatic Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Pancreatic Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by re

View Details

PharmaPoint: HER2-Negative/HR+ and Triple Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2025 Summary Human epidermal growth factor receptor type 2 (HER2-) breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. HER2-negative breast cancer can be subdivided into hormone receptor-positive (HER2-/HR+), and triple negative breast cancer (TNBC). The prognoses of HER2-/HR+ and TNBC differ dramatically, as patients with TNBC pr

View Details

PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2025 Summary GlobalData estimates sales of dyslipidemia therapeutics to be approximately $11.2B across the 7MM in 2015, encompassing the US, 5EU, and Japan. The dyslipidemia market will grow at a strong CAGR of 10.1% over the forecast period, reaching sales of $29.2B by 2025. The US is the largest market for dyslipidemia therapies, contributing approximately 61.5% of total sales in the base year. GlobalData expects uptake

View Details

PharmaPoint: Hepatitis C Virus (HCV) Therapeutics - Global Drug Forecast and Market Analysis to 2025 Summary The hepatitis C virus (HCV) is a small, enveloped RNA virus that causes acute and chronic infections of the liver and, if left untreated, can result in fibrosis, permanent liver damage (cirrhosis), HCC, and eventually death. A member of the Flaviviridae viral family and hepacivirus genus, HCV can be classified into six major genotypes, with many additional subtypes within each genotype.

View Details

OpportunityAnalyzer: Diabetic Foot Ulcers - Opportunity Analysis and Forecast to 2025 Summary GlobalData estimates sales of diabetic foot ulcer (DFU) and diabetic foot infection (DFI) drugs to be approximately $292.1M across the 7MM in 2015, encompassing the US, 5EU, and Japan. DFU sales alone accounting for $118.7M across the 7MM. The DFU, DFI market will grow at a CAGR of 11.6% over the forecast period, reaching sales of $873.4M by 2025. The US is the largest market for DFU, DFI therapies, c

View Details

OpportunityAnalyzer: Hyperparathyroidism - Opportunity Analysis and Forecasts to 2025 Summary Hyperparathyroidism (HPT) is a common endocrinal disorder characterised by excessive plasma levels of parathyroid hormone (PTH) stemming from overactivity of the parathyroid glands. The parathyroid glands, of which there are four, regulate physiological calcium homeostasis through a negative feedback mechanism involving PTH secretion. HPT is classified into either primary, secondary, or tertiary, and

View Details

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Russia Summary GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Russia”. This report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Russia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement lan

View Details

Market Reports Center © Copyright 2017 All rights reserved.

wire transfer
ssl